RRX:NYSERegal Rexnord Corporation Analysis
Data as of 2026-06-09 - not real-time
$210.28
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Regal Rexnord posted a modest 4.3% year‑over‑year revenue increase to $1.48 bn and beat earnings expectations by roughly 2% in Q1 2026, but the market reacted sharply, with the stock sliding more than 8% after hours. Technical indicators are mixed: the 20‑day SMA (≈$204) sits just below the current price of $210, the MACD shows a bullish divergence, yet the 30‑day volatility is high at 58% and volume is trending down, hinting at potential pressure. The valuation metrics underscore concern – a trailing P/E of 49× dwarfs the industry average of 30×, while a DCF‑derived fair value of $119 is far below the market price, suggesting the stock is currently overvalued. Fundamentally, the company maintains a low payout ratio (≈33%), solid operating cash flow of $0.9 bn, and an improving order backlog (+8.5% YoY), but it carries a hefty debt load (Debt/Equity > 70) and a modest ROE of 4.3%. The dividend yield of 0.67% is modest but appears sustainable given the cash generation. Looking ahead, the strong order momentum and exposure to growth‑oriented sectors such as automation and aerospace could drive earnings, yet the high valuation and elevated beta (≈2.0) mean investors should weigh upside against heightened risk.
In the short term, the stock sits near its technical resistance around $218 and may face further downside if earnings momentum stalls, but the bullish MACD and resilient order flow provide a cushion. Over the medium horizon, the forward P/E of 15.5× indicates analysts expect earnings acceleration, aligning with the company's 13.5 EPS forecast, though price appreciation may be constrained by valuation gaps. For long‑term investors, the secular demand for industrial automation and a sustainable dividend offer an attractive risk‑adjusted profile, provided the company can deleverage and improve margins.
In the short term, the stock sits near its technical resistance around $218 and may face further downside if earnings momentum stalls, but the bullish MACD and resilient order flow provide a cushion. Over the medium horizon, the forward P/E of 15.5× indicates analysts expect earnings acceleration, aligning with the company's 13.5 EPS forecast, though price appreciation may be constrained by valuation gaps. For long‑term investors, the secular demand for industrial automation and a sustainable dividend offer an attractive risk‑adjusted profile, provided the company can deleverage and improve margins.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Recent earnings beat offset by sharp post‑earnings sell‑off
- High valuation relative to fair value
- Bullish MACD but decreasing volume and elevated volatility
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong order backlog and expected earnings acceleration (forward EPS $13.5)
- Forward P/E compression to 15.5× indicating growth expectations
- Persistent overvaluation and high debt levels
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular demand for automation and motion‑control solutions
- Sustainable dividend with low payout ratio
- Robust cash flow generation to support deleveraging and margin improvement
Key Metrics & Analysis
Financial Health
Revenue Growth4.30%
Profit Margin4.78%
P/E Ratio49.0
ROE4.34%
ROA3.15%
Debt/Equity71.34
P/B Ratio2.1
Op. Cash Flow$903.4M
Free Cash Flow$787.2M
Industry P/E30.1
Technical Analysis
TrendNeutral
RSI53.2
Support$180.80
Resistance$218.27
MA 20$203.94
MA 50$204.08
MA 200$170.82
MACDBullish
VolumeDecreasing
Fear & Greed Index87.64
Valuation
Fair Value$118.64
Target Price$251.56
Upside/Downside19.63%
GradeOvervalued
TypeGrowth
Dividend Yield0.67%
Risk Assessment
Beta2.03
Volatility58.39%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.